Antios Therapeutics Initiates First-in-Human Phase I Study of ATI-2173

Emory, collaborators testing antiviral drug as potential treatment for coronaviruses

New drug forces flu virus into ‘error catastrophe,’ overwhelming it with mutations

Drug Innovation Ventures at Emory (DRIVE) and Antios Therapeutics announce license for hepatitis B drug

What is Drug Innovation Ventures at Emory?

Georgia Bio honors Emory drug innovator with Georgia Bio Community Award

NPR’s Closer look examines DRIVE and EIDD

DRIVE CEO George Painter hiking in Death Valley

DRIVE founder Dennis Liotta discusses drugs for neglected diseases at TEDx Geneva

Emory Scientists Developing Drugs To Treat Zika Virus